Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

New thrombin inhibitors presented by Merck & Co. research group

Jan. 6, 2000

Condensed heterocycles and ester prodrugs as potent antiplatelet, antithrombotic agents

Jan. 5, 2000

Merck describes thrombin-specific anticoagulants

Jan. 3, 2000

New approach to inhibiting thrombin-induced neuronal cell death

Dec. 29, 1999

Update on preclinical and clinical testing of R.W. Johnson's fibrinogen antagonist

Dec. 27, 1999

Recently issued patent covers Berlex's new anticoagulants

Dec. 23, 1999

Selective, orally active factor Xa inhibitors designed by JT scientists

Dec. 22, 1999

Meiji Seika presents heterocyclic inhibitors of platelet aggregation

Dec. 22, 1999

Orally active antiplatelet agents derived from isoquinolone leads at Lilly

Dec. 21, 1999

Hungarian team describes novel orally active antithrombotic agents

Dec. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...